info@marketresearchfuture.com   ūüďě  +1 (855) 661-4441(US)   ūüďě  +44 1720 412 167(UK)
Certified Global Research Member
Isomar fd.webp Wcrc 57.webp
Key Questions Answered
  • Global Market Outlook
  • In-depth analysis of global and regional trends
  • Analyze and identify the major players in the market, their market share, key developments, etc.
  • To understand the capability of the major players based on products offered, financials, and strategies.
  • Identify disrupting products, companies, and trends.
  • To identify opportunities in the market.
  • Analyze the key challenges in the market.
  • Analyze the regional penetration of players, products, and services in the market.
  • Comparison of major players financial performance.
  • Evaluate strategies adopted by major players.
  • Recommendations
Why Choose Market Research Future?
  • Vigorous research methodologies for specific market.
  • Knowledge partners across the globe
  • Large network of partner consultants.
  • Ever-increasing/ Escalating data base with quarterly monitoring of various markets
  • Trusted by fortune 500 companies/startups/ universities/organizations
  • Large database of 5000+ markets reports.
  • Effective and prompt pre- and post-sales support.

Asia Pacific Orthopedic Biomaterial Market Research Report Information, By Type Of Material (Metal, Non-Metal), By Application (Joint Replacement, Fracture Fixation Devices, Tissue Fixation, Spine Implants Viscosupplementation, And Others), And By End Users (Hospital, Clinics) - Forecast Till 2030


ID: MRFR/MED/0200-HCR | 50 Pages | Author: Rahul Gotadki| June 2024

Asia Pacific Orthopedic Biomaterial Market Overview


The Orthopedic Biomaterial Market of asia pacific is expected to reach USD 40,519.52 million by 2030 at 10.5% CAGR during the forecast period 2022-2030. Orthopedic biomaterials are organic or synthetic materials used for the treatment of internal fractures. During the last decade different new techniques and materials are introduced for orthopedic implants and surgeries and biomaterials have found a vital role in it. 


Asia Pacific Orthopedic Biomaterial Market


These biomaterials are used in manufacturing of different implants since they do not evoke any immunological reactions with the body, which makes it a first choice for manufacturing of implants. Increasing demand for the orthopedic biomaterial because of its application in knee and hip replacement surgeries, and increasing incident of medical emergencies drive the Asia Pacific orthopedic biomaterial market.


Introduction of novel implants of titanium has increased the success rate of implant surgeries and also contributed to the growth of the orthopedic market in Asia Pacific. Moreover, increasing number of orthopedic surgeries, increasing aging population, and growing governmental support also drive the Asia Pacific market. However, increasing failure in joints implants, stringent regulatory laws, and high cost of treatment may hinder the growth of Asia Pacific orthopedic biomaterial market during the review period.


Orthopedic biomaterials might be artificial or natural. They are made to be inserted into a person's body as parts of machines that are intended to carry out certain biological tasks by replacing or mending various tissues. Orthopedic biomaterials are utilized for tissue fixation, spine implants, joint replacements, and other orthopedic procedures. Additionally, the need for next-generation orthopedic biomaterials specifically designed to fulfill the requirements of a particular orthopedic operation is on the rise globally. On the other hand, the market's expansion has been hampered by the restricted payment coverage alternatives for these devices and the falling reimbursement for orthopedic implants in several nations. Additionally, the lack of rebates has forced suppliers to reduce the cost of these products, which has slowed market expansion.


The growing geriatric population, rising incidence rates of accidents and sports-related injuries, rising awareness of orthopedic biomaterials, and introduction of novel products by major market players are a few of the factors anticipated to boost market growth over the forecast period. Fewer traffic accidents and injuries occurred due to the pandemic's widespread lockdowns, curtailing private and public transit. As a result, the focus of healthcare institutions shifted from operations to COVID-19 patients. This immediately affected the market during the early pandemic phase, especially in specialist hospitals. Increased bone fractures, disc degenerative disorders, and more trauma cases are predicted to increase product demand in this market. Due to factors like the rising geriatric population, increasing incidence rates of accidents and sports-related injuries, and rising awareness of orthopedic biomaterials.


CitrefixTM, a suture anchor system for surgical procedures on the foot and ankle, was introduced by Stryker. The new technology uses CitregenTM, a highly acclaimed bioresorbable substance created to imitate the composition and structure of natural bone. Citrefix is a resorbable, bio-inspired suture anchor system for single-use sutures. Citregen, an elastomeric substance formed from a citrate polymer and specifically created to imitate bone chemistry for regulated resorption without persistent inflammation, is used in its construction. These special chemical and mechanical qualities are intended to promote healthy bone growth and heal transplanted tissue when used in orthopedic surgical procedures.


Asia Pacific Orthopedic Biomaterial Market Key Players


Some of the major players in Asia Pacific orthopedic biomaterial market: 



  • Kyocera Corporation (Japan)

  • Materion Corporation (US)

  • S&V Technologies (Germany)

  • Rayner (UK), InVision Biomedical (US)

  • Covestro (Germany)

  • Invibio Ltd. (U.K.)

  • Royal DSM (Netherlands)

  • BASF SE (Germany)

  • Corbion N.V. (Netherlands)

  • CeramTec (Germany)

  • Tianjin Walkman Biomaterial Co. (China)

  • Kanghui Holdings (China)

  • Johnson & Johnson Services, Inc. (US)

  • Cam Bioceramics B.V. (Netherland)

  • Xian Airfoil Technology Co (China)


Asia Pacific Orthopedic Biomaterial Market Segmentation


The orthopedic biomaterials market is segmented on the basis of types of material, applications, and end users. On the basis of types of material, the market is segmented into metals and non-metals.  The metals are further segmented into stainless steel, titanium alloy, cobalt alloy, and others. Non-metal are further segmented into ceramic, polymeric, natural biomaterials, and others. The ceramic are sub-segmented into alumina, calcium phosphate, zirconium dioxide, carbon, and others. The polymeric materials are sub-segmented into polymethylmethacrylate (PMMA), polyethylene, silicone, polyester, and other. The natural biomaterials are sub-segmented into collagen, chitin & chitosan, and other


On the basis of applications, the Asia Pacific orthopedic biomaterial market is segmented into joint replacement, fracture fixation devices, tissue fixation, spine implants, viscosupplementation, and other. Joint replacement is sub-segmented into hip replacement, knee replacement, shoulder and elbow replacement, and other. Tissue fixation is sub-segmented into interference screws, suture anchors, and others. Spine implants are further sub-segmented into spine fusion and other. The fracture fixation devices are sub segmented into screws, plates for bones, rods, and other.


On the basis of end users, the Asia Pacific orthopedic biomaterial market is segmented into hospital, clinics, and others.The first surgical application of Acuitive Technologies, Inc.'s (Acuitive) Citrelock® ACL Tendon Fixation Device was disclosed. The novel ACL device offers orthopedic surgeons a unique design thanks to a tendon-friendly spiral thread made of Citregen, a next-generation resorbable material with special molecular and mechanical characteristics. With its cutting-edge material technology and distinctive design, the Citrelock ACL Tendon Fixation Device contributes to meeting this therapeutic requirement. The Citrelock ACL System is an exciting new addition to Acuitive's line of products and the first of many that we will be releasing with an emphasis on the sports medicine sector.


Asia Pacific Orthopedic Biomaterial Market Regional Analysis


China dominates the Asia Pacific orthopedic biomaterial market owing to increasing prevalence of different orthopedic surgeries in China. Increasing awareness of biodegradable products among the people, rapid research and development and huge aging population in this region have added fuel to the growth of the market. Japan and Australia are other major contributor of the Asia Pacific orthopedic biomaterial market in this region. 


Intended Audience



  • Product manufacturers

  • Biomaterial manufacturer

  • Research and development (R&D) companies

  • Hospitals and laboratories

  • Medical research laboratories

  • Academic medical institutes and universities

Report Attribute/Metric Details
  Market Size   USD 40,519.52 million
  CAGR   10.5%
  Base Year   2021
  Forecast Period   2022-2030
  Historical Data   2020
  Forecast Units   Value (USD Million)
  Report Coverage   Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
  Segments Covered   By Product Type, Material Class
  Geographies Covered   North America, Europe, Asia Pacific
  Key Vendors   Stryker (US) CoorsTek Inc. (US) Zimmer Biomet Holdings Inc. (US) Institut Straumann AG (Switzerland) Kyocera Corporation (Japan) Smith & Nephew plc (UK) 3M (US) Nobel Biocare Services AG(Switzerland) Medtronicplc (Ireland) DePuy Synthes (US)
  Key Market Opportunities   Technological advancement in the medical implants market
  Key Market Drivers   Increasing older population leading to an increase in the patient population
 

Frequently Asked Questions (FAQ) :

The Asia Pacific Orthopedic Biomaterial Market CAGR would be 10.5% during the forecast period (2022-2030).

End users in the Asia Pacific Orthopedic Biomaterial Market are hospitals, clinics, and others.

China would dominate the Asia Pacific Orthopedic Biomaterial Market.

The applications of the Asia Pacific Orthopedic Biomaterial Market are viscosupplementation, fracture fixation devices, joint replacement, spine implants, tissue fixation, and other

Players involved are Materion Corporation (US), Kyocera Corporation (Japan), InVision Biomedical (US), S&V Technologies (Germany), Rayner (UK), Invibio Ltd. (U.K.), Royal DSM (Netherlands), Covestro (Germany), Corbion N.V. (Netherlands), BASF SE (Germany), Tianjin Walkman Biomaterial Co. (China), CeramTec (Germany), Cam Bioceramics B.V. (Netherland), Johnson & Johnson Services, Inc. (US), Kanghui Holdings (China), and Xian Airfoil Technology Co (China).

Leading companies partner with us for data-driven Insights
client_1 client_2 client_3 client_4 client_5 client_6 client_7 client_8 client_9 client_10
Kindly complete the form below to receive a free sample of this Report
Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Purchase Option
Single User $ 4,950
Multiuser License $ 5,950
Enterprise User $ 7,250
Compare Licenses
Tailored for You
  • Dedicated Research on any specifics segment or region.
  • Focused Research on specific players in the market.
  • Custom Report based only on your requirements.
  • Flexibility to add or subtract any chapter in the study.
  • Historic data from 2014 and forecasts outlook till 2040.
  • Flexibility of providing data/insights in formats (PDF, PPT, Excel).
  • Provide cross segmentation in applicable scenario/markets.